Targeted Oncology |
Verstovsek Clarifies Risk Stratification and Management in Patients With Polycythemia Vera
Targeted Oncology If the patient has low-risk disease, then we do phlebotomy to decrease the hematocrit—one of the parameters for measuring red blood cells—to below 45%, and maybe aspirin to make blood flow easier to decrease the stickiness between the cells. |
from phlebotomy - Google News http://bit.ly/2xwr1EI
No comments:
Post a Comment